Pages that link to "Q66732793"
Jump to navigation
Jump to search
The following pages link to Larisa Gubareva (Q66732793):
Displaying 50 items.
- Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors (Q27013442) (← links)
- Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors (Q28263525) (← links)
- Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein (Q28471835) (← links)
- Molecular epidemiology of influenza A(H1N1)pdm09 viruses from Pakistan in 2009-2010 (Q28482417) (← links)
- Genomic Signature-Based Identification of Influenza A Viruses Using RT-PCR/Electro-Spray Ionization Mass Spectrometry (ESI-MS) Technology (Q28748906) (← links)
- Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness (Q30205712) (← links)
- Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011. (Q30218773) (← links)
- Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay (Q30308218) (← links)
- Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA. (Q30308801) (← links)
- A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site (Q30310145) (← links)
- Assessment of hemagglutinin sequence heterogeneity during influenza virus transmission in families. (Q30310247) (← links)
- Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. (Q30353535) (← links)
- Outbreak of variant influenza A(H3N2) virus in the United States. (Q30353883) (← links)
- Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. (Q30363279) (← links)
- Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses (Q30372421) (← links)
- Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. (Q30374227) (← links)
- Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013 (Q30377552) (← links)
- Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. (Q30382312) (← links)
- Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008. (Q30382408) (← links)
- Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. (Q30383771) (← links)
- Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses. (Q30386603) (← links)
- In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses (Q30387420) (← links)
- 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication (Q30389518) (← links)
- Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays (Q30390818) (← links)
- Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins (Q30392944) (← links)
- Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility in vitro (Q30397287) (← links)
- RT-PCR/electrospray ionization mass spectrometry approach in detection and characterization of influenza viruses (Q30397685) (← links)
- Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States (Q30399317) (← links)
- Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico (Q30399321) (← links)
- Detection of hemagglutinin variants of the pandemic influenza A (H1N1) 2009 virus by pyrosequencing (Q30399501) (← links)
- Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009 (Q30400049) (← links)
- An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses (Q30407144) (← links)
- Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective (Q30408105) (← links)
- A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes (Q30410546) (← links)
- Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives (Q30410899) (← links)
- Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11 (Q30412554) (← links)
- Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods (Q30412663) (← links)
- Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States (Q30413041) (← links)
- The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors (Q30415934) (← links)
- The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors (Q30415937) (← links)
- Monitoring seasonal influenza A evolution: rapid 2009 pandemic H1N1 surveillance with an reverse transcription-polymerase chain reaction/electro-spray ionization mass spectrometry assay (Q30417651) (← links)
- Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model (Q30436323) (← links)
- Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N. (Q30437696) (← links)
- Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors (Q30438033) (← links)
- Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors (Q30438502) (← links)
- Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. (Q30439301) (← links)
- Recovery of drug-resistant influenza virus from immunocompromised patients: a case series (Q30439558) (← links)
- Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection (Q30439560) (← links)
- Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection (Q30440030) (← links)
- In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication (Q30453074) (← links)